Most Recent
Judgments shooting down a class closure order and nixing notice of a possible class closure order were "plainly wrong" and "infected" by faulty reasoning, the Full Federal Court has heard.
An appeal in a class action over Ford's alleged defective Powershift transmission could blow out by a week, with the applicant filing a cross appeal in a case that comes down to three provisions of the Australian Consumer law given little or no attention by the Full Court.
A second class action investigation against regenerative medicine company Mesoblast is underway, this one looking at claim it misled shareholders about the potential application of a developmental stem cell product to treat terminally-ill children.
Scenic Tours is facing a potential second class action over a series of European cruises that went ahead in 2018 despite a record-breaking drought that saw river levels drop so low they became impassable.
A funder that's helping foot the bill in a class action against Arrium's former directors and KPMG may withdraw support if the law firm that's running it is not granted an order awarding it 40 per cent of any award or settlement.
An appellate victory by insurers in a test case over business interruption coverage for losses stemming from the COVID-19 pandemic does not spell the end to class actions brought on behalf of businesses whose claims were denied, according to a lawyer for the class actions.
Virgin Australia is facing a shareholder class action investigation over representations made in a 2019 prospectus for a capital raising to fund its $700 million acquisition of the Velocity loyalty program, issued six months before the airline filed for administration.
An appeals court challenge by a group of small businesses seeking coverage under business interruption insurance policies for losses flowing from COVID-19 restrictions has largely failed.
BHP Group has been granted special leave from the High Court to appeal a ruling that rejected its bid to exclude foreign investors from a shareholder class action over the 2015 Fundao dam disaster.
The funder that was bankrolling a class action alleging pharmacy giant Priceline exercised an "overly prescriptive level of control" on franchisees which limited their profitability has withdrawn its support for the proceeding.